There are at least 200 distinct forms of cancer, with many additional subtypes within each. That number comes from broad clinical classification, but it keeps growing. As genetic testing reveals molecular differences between tumors that look identical under a microscope, the real count of meaningfully distinct cancers stretches into the hundreds or even thousands depending on how you define “a cancer.”
Why the Number Is Hard to Pin Down
Cancer isn’t one disease. It’s an umbrella term for any condition where cells grow uncontrollably and can invade surrounding tissue. You can count cancers by where they start in the body (lung, breast, colon), by the type of cell they arise from (epithelial, bone, blood), or by their molecular fingerprint. Each method gives you a different total.
A tumor that starts in the lung lining and one that starts in the lung’s connective tissue are fundamentally different diseases with different behaviors and different treatments, even though both are loosely called “lung cancer.” This layering of organ, cell type, and genetics is what makes a single definitive count impossible.
The Five Major Categories
Despite the complexity, nearly every cancer falls into one of five broad groups based on which type of cell it originates from.
Carcinomas are by far the most common, accounting for 80 to 90 percent of all cancer cases. They start in epithelial tissue, the cells that line your organs, skin, and internal surfaces. Breast, lung, prostate, and colon cancers are all carcinomas. They split into two main subtypes: adenocarcinomas, which form in organs or glands, and squamous cell carcinomas, which form in flat surface cells like those lining the throat or skin.
Sarcomas start in connective and supportive tissues: bone, cartilage, muscle, fat, and blood vessels. They’re far less common than carcinomas but include a wide range of specific diseases, from osteosarcoma (bone) to liposarcoma (fat tissue) to rhabdomyosarcoma (skeletal muscle). More than a dozen recognized sarcoma types exist.
Leukemias are cancers of the bone marrow and blood. Sometimes called “liquid cancers,” they typically involve the overproduction of abnormal white blood cells. The major forms are myelogenous leukemia, which affects one lineage of white blood cells, and lymphocytic leukemia, which affects another. Each comes in acute (fast-growing) and chronic (slow-growing) versions.
Lymphomas develop in the lymphatic system, the network of nodes, vessels, and organs (including the spleen, tonsils, and thymus) that filters body fluids and produces immune cells. The two main categories are Hodgkin lymphoma and non-Hodgkin lymphoma, which is itself a collection of more than 60 subtypes.
Myelomas originate in plasma cells, a type of immune cell in bone marrow that produces antibodies. Multiple myeloma, where cancerous plasma cells accumulate in several bones at once, is the most well-known form.
The Most Common Cancers Worldwide
Lung cancer is the most frequently diagnosed cancer globally, with nearly 2.5 million new cases per year, roughly 1 in every 8 cancer diagnoses. It’s also the deadliest overall, responsible for about 1 in 5 cancer deaths. In men, prostate and colorectal cancers follow lung cancer in frequency. In women, breast cancer is the most commonly diagnosed and the leading cause of cancer death, followed by lung, colorectal, and cervical cancers.
These handful of common cancers get the most attention and research funding. But the majority of the 200-plus cancer types are individually rare. The European RARECARE project defines a rare cancer as one with fewer than 6 new cases per 100,000 people per year. Using that threshold, surveillance programs track at least 69 distinct categories of rare cancers. Collectively, rare cancers affect a significant number of people even though each individual type does not.
Molecular Subtypes Are Multiplying the Count
The traditional way to classify cancer, by looking at tumor cells under a microscope, has been supplemented by molecular profiling that examines what’s happening inside the cell’s DNA and proteins. This has dramatically expanded the number of meaningful cancer subtypes.
Breast cancer illustrates this well. Clinically, breast tumors are sorted into three receptor-based subtypes depending on whether they’re fueled by hormones, by a growth protein called HER2, or by neither (triple-negative). But genetic analysis has gone much further. One landmark study identified 10 distinct molecular clusters of breast cancer, each with unique genetic patterns. Triple-negative breast cancer alone, which represents about 15 percent of breast cancers, has been subdivided into 4 to 6 molecular subtypes by different research teams. HER2-positive breast cancer has been split into 4 subgroups. Hormone-receptor-positive breast cancer has been classified into another 4.
The same pattern holds across other cancers. The NIH’s Pan-Cancer Atlas project performed genomic analysis on 33 cancer types and found that tumors traditionally grouped together by organ often share more molecular features with cancers in completely different organs than with their supposed neighbors. A bladder cancer might look more like a lung cancer at the molecular level than like another bladder cancer. This reshuffling of cancer identity means the practical number of distinct diseases doctors need to treat is significantly larger than 200 and continues to grow as testing improves.
Children Get Different Cancers Than Adults
The types of cancer that affect children are strikingly different from those in adults. Childhood cancers most commonly involve blood cells, the lymphatic system, the brain, adrenal glands, and bones. The single most common childhood cancer is acute lymphoblastic leukemia. The cancers that dominate adult statistics, including prostate, breast, colon, and lung cancer, are extremely rare in children.
There’s another key difference: childhood cancers are not linked to lifestyle factors like diet, smoking, or sun exposure the way many adult cancers are. They tend to arise from errors in cell development rather than accumulated environmental damage over decades. Recovery rates are also substantially higher. Most children diagnosed with cancer today can be cured.
How Cancers Get Their Names
Cancer names typically combine the tissue or cell type with the category. An adenocarcinoma of the lung is a cancer of glandular cells in the lung. An osteosarcoma is a cancer of bone connective tissue. A lymphoblastic leukemia is a blood cancer involving immature lymph cells. Once you understand the five major categories, most cancer names become readable: the prefix tells you the cell type, and the suffix tells you the category.
Some cancers break from this pattern and carry the name of the doctor who first described them (Hodgkin lymphoma, Ewing sarcoma) or use a more colloquial name (melanoma for the pigment-cell skin cancer). But the underlying logic is the same: every cancer is defined first by the type of cell it started in, then further refined by its location and, increasingly, by its molecular profile.